Leerink Partners downgrades Amicus Therapeutics stock on BioMarin acquisition December 29, 2025December 29, 2025 · Business · By ReportWire Leerink Partners downgrades Amicus Therapeutics stock on BioMarin acquisition Investing.com Source link